Keywords
Morbid Obesity Obesity Surgery Adjustable Laparoscopic Gastric Banding Laparoscopic Gastric Banding Sulfapyridine
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
- 1.Deitel M, Gawdat K, Melissas J. Reporting weight loss 2007 (Editorial). Obes Surg 2007; 17: 565–8.CrossRefPubMedGoogle Scholar
- 2.Kuczmarski RJ, Flegal KM. Criteria for definition of overweight in transition: background and recommendations for the United States. Am J Clin Nutr 2000; 72: 1074–81.PubMedGoogle Scholar
- 3.Martin LF, Smits GJ, Greenstein RJ. Treating morbid obesity with adjustable laparoscopic gastric banding. Am J Surg 2007 (in press).Google Scholar
- 4.Deitel M, Greenstein RJ. Recommendations for reporting weight loss (Editorial). Obes Surg 2003; 13: 159–60.CrossRefPubMedGoogle Scholar
- 5.Greenstein RJ, Belachew M. Implantable gastric stimulation (IGS®) as therapy for human morbid obesity: Report from the 2001 IFSO Symposium in Crete. Obes Surg 2002; 12 (Suppl 1): 3S-5S.CrossRefPubMedGoogle Scholar
- 6.Cigaina V. Gastric pacing as therapy for morbid obesity: preliminary results. Obes Surg 2002; 12 (Suppl 1):12S-16S.CrossRefPubMedGoogle Scholar
- 7.Greenstein RJ, Su L, Shahidi A et al. On the action of 5-amino-salicylic acid and sulfapyridine onM. avium including subspeciesparatuberculosis. PLoS ONE 2007; 2: e516.Google Scholar
References
- 1.Deitel M, Gawdat K, Melissas J. Reporting weight loss 2007 (Editorial). Obes Surg 2007;17: 565–8.CrossRefPubMedGoogle Scholar
Copyright information
© Springer 2007